^a Tested in PVC containers.

^b Tested in polyisoprene infusion pump reservoirs.

^c Tested in polyolefin-lined plastic bags.

^d Tested in PVC reservoirs for the Graseby 9000 ambulatory pumps.

^e Tested with ondansetron HCl (GL) 640 mg/L.

^f Tested with vincristine sulfate (LI) 1.6 mg/L.

^g Tested with vincristine sulfate (LI) 1 mg/L.

^h Tested with vincristine sulfate (LI) 1.4 mg/L.

ⁱ Tested with vincristine sulfate (LI) 2 mg/L.

^j Tested with vincristine sulfate (LI) 2.8 mg/L.

^k Tested with vincristine sulfate (LI) 4 mg/L.

^l Tested with vincristine sulfate (LI) 5 mg/L.

^m Tested with vincristine sulfate (LI) 10 mg/L.

ⁿ Tested with vincristine sulfate (LI) 16 mg/L.

^o Tested with dacarbazine (LY) 8 g/L.

^p Tested with dacarbazine (LY) 20 g/L.

^q Tested with vincristine sulfate (LI) 14 mg/L.

^r Tested with vincristine sulfate (LI) 28 mg/L.

^s Tested with etoposide (BMS) 200 mg/L.

^t Tested with etoposide (BMS) 125 mg/L.

^u Tested with etoposide (BMS) 175 mg/L.

^v Tested with etoposide (BMS) 250 mg/L.

^w Tested with etoposide (BMS) 350 mg/L.

^x Tested with etoposide (BMS) 500 mg/L.

^y Tested with etoposide phosphate (BMS) 600 mg/L.

^z Tested with etoposide phosphate (BMS) 1.2 g/L.

^aa Tested with etoposide phosphate (BMS) 2 g/L.

^bb Tested with ondansetron HCl (GL) 480 mg/L.

^cc Tested with ondansetron HCl (GL) 960 mg/L.